[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100407514":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":28,"centralContacts":32,"locations":41,"responsibleParty":58,"collaborators":10,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":10,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":10,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Medialis Ltd.","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-hospitalised post-COVID-19 patients",null,"This cohort will have had a confirmed positive test for COVID-19 or antibody test confirming they had COVID-19 but they were not hospitalised for this",[13],"Other: No intervention - quality of life measure",{"label":15,"type":10,"description":16,"interventionNames":17},"Hospitalised post-COVID-19 patients","This cohort will have a confirmed diagnosis of COVID-19 and been hospitalised but were not in an Intensive Care Unit",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Intensive care post-COVID-19 patients","This cohort will have a confirmed diagnosis of COVID-19 and been hospitalised in an Intensive Care Unit",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"OTHER","No intervention - quality of life measure","Participants will be part of the creation of a Post-COVID-19 quality of life measure if involved in Phase One. In Phase Two participants will complete this post-COVID-19 quality of life measure monthly for 12 months",[15,19,9],[29],{"name":30,"affiliation":5,"role":31},"Ravi Jandhyala","STUDY_CHAIR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Omolade Femi-Ajao, PhD","CONTACT","+447502228066","research@medialis.co.uk",{"name":30,"role":35,"phone":39,"phoneExt":10,"email":40},"44(0)7717 448656","ravi@medialis.co.uk",[42],{"facility":43,"status":44,"city":45,"state":10,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Medialis","RECRUITING","Oxford","OX16 0AH","United Kingdom","UK",{"type":50,"coordinates":51},"Point",[52,53],-1.25596,51.75222,{"lat":53,"lon":52},[56],{"name":30,"role":35,"phone":57,"phoneExt":10,"email":40},"44(0)1744865",{"type":59,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100407514","post-acute-covid-19-quality-of-life-pac-19qol-tool-development-and-patient-registry-pac-19qolreg-100407514",false,"NCT04586413","Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)","Phase One\n\nInclusion Criteria:\n\n* The participant has had either a confirmed COVID-19 test while infected or a confirmed COVID-19 antibody test post-infection\n* The participant is aged 18 years or older\n* The participant is capable of providing informed consent\n* The participant can read, write and converse in English\n* The participant can comply with the study schedule\n\nExclusion Criteria:\n\n* The participant does not have a confirmed COVID-19 test or antibody test\n* The participant is aged under 18 years\n* The participant is not capable of giving informed consent\n* The participant is unable to read, write and converse in English\n* The participant is unable to comply with study schedule data collection\n\nPhase Two\n\nInclusion Criteria:\n\n* The participant has had either a confirmed COVID-19 test while infected or a confirmed COVID-19 antibody test post-infection or a clinical diagnosis of COVID-19\n* The participant is aged 18 years or older\n* The participant is capable of providing informed consent\n* The participant can read, write and converse in English\n* The participant can comply with the study schedule\n\nExclusion Criteria:\n\n* The participant does not have a confirmed COVID-19 test or antibody test or clinical diagnosis of COVID-19\n* The participant is aged under 18 years\n* The participant is not capable of giving informed consent\n* The participant is unable to read, write and converse in English\n* The participant is unable to comply with study schedule data collection","ALL","18 Years",{"count":69,"type":70},100,"ESTIMATED","OBSERVATIONAL","Coronavirus Disease 2019 (COVID-19) is a newly emerged disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 pandemic is having a large impact on the mental and physical health of patients, yet data on the quality of life of post-COVID-19 patients is lacking. There are currently no post-COVID-19 specific measures for quality of life, particularly none which include the views of post-COVID-19 patients themselves. This observational study will recruit participants to contribute their preferences to the creation of a post-COVID-19 specific patient-reported measure on post-COVID-19 quality of life. Participants will be split into three groups: those who were not hospitalised; those who were hospitalised but not in intensive care units; and those who were hospitalised and in intensive care units. The creation of this measure will form phase 1 of the study, with 30-60 participants (10-20 in each group above) recruited to complete online surveys to find out their preferences of areas of life to include in such a measure. This will involve 3 online surveys, 1) to ask which areas of life they feel are impacted and how; 2) to find consensus about the areas to be included; 3) to weight the relevance of these areas in relation to each other. In phase 2 recruitment will open to additional participants and all participants will be asked to complete the finalised post-COVID-19 quality of life measure once a month for 12 months, aiming for a minimum of 100 participants at this stage. All participants will also be asked to complete a demographic questionnaire to inform the analysis of the data.",[74],"Covid19",[74,76,77],"Quality of Life","Post-Covid19","2023-10-19",{"date":80,"type":81},"2023-10-23","ACTUAL",{"date":83,"type":81},"2020-10-07",{"date":85,"type":70},"2028-10",{"name":5,"class":6},1]